Haploidentical Hematopoietic Stem Cell Transplantation
NCT02165007
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell-thalassemia Disease
Thalassemia
Interventions
DRUG:
peripheral blood stem cell graft that are CD34+ selected
Sponsor
Catherine Bollard
Collaborators
[object Object]